Actively Recruiting
Effects of an ACT-based Psychological Treatment in Patients With Chronic Kidney Disease
Led by Universidad Europea de Madrid · Updated on 2025-04-23
104
Participants Needed
1
Research Sites
138 weeks
Total Duration
On this page
Sponsors
U
Universidad Europea de Madrid
Lead Sponsor
F
Fundación Renal Iñigo Alvarez De Toledo
Collaborating Sponsor
AI-Summary
What this Trial Is About
Investigation of the efficacy of Acceptance and Commitment Therapy (ACT) for the psychological treatment of patients with chronic kidney disease.
CONDITIONS
Official Title
Effects of an ACT-based Psychological Treatment in Patients With Chronic Kidney Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with chronic kidney disease on haemodialysis
- Older than 18 years-old
- At least 3 months on haemodialysis
- HADS Global Scale Score 14
You will not qualify if you...
- Diagnosis of severe or chronic mental disorder, mental retardation and cognitive impairment, or disabling illness
- Antidepressant drugs consume
- Insufficient understanding of Spanish
- Patients who are in the Advanced Chronic Kidney Disease Unit
- Receiving other psychological treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fundación Renal Iñigo Alvarez de Toledo
Madrid, Spain, 28003
Actively Recruiting
Research Team
F
Francisco Montesinos, Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here